Articles |
From the Division of Cardiovascular Research (S.O., T.C., M.R.), Research Institute, The Hospital for Sick Children, and the Vascular Research Laboratory (E.W.Y.K., S.J.D., A.I.G.), The Toronto Hospital Research Institute and the Departments of Pediatrics, Pathology, and Medicine, University of Toronto, Canada.
Correspondence to Marlene Rabinovitch, MD, Division of Cardiovascular Research, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8.
Abstract We investigated the association between tissue
elastolytic activity and the development of neointimal
formation using a previously described porcine aortic organ culture.
Neointimal formation is associated with the presence of
intact endothelium (nondenuded cultures) but is
markedly reduced if endothelial cells are removed
(denuded cultures). In nondenuded organ cultures, elastolytic activity
assessed by using [3H]elastin increased sixfold at day 3
after initiation of the culture (P<.01), a time earlier
than the previously published increase in intimal smooth muscle cells
(ISMCs). Elastolytic activity did not increase from day 3 to day 7
despite doubling of ISMCs but did double by day 14 (P<.01)
and remained elevated to day 28, correlating with increases in ISMCs.
In denuded organ cultures, elastolytic activity was much lower than in
nondenuded organ cultures at day 3 (P<.05) but increased
fivefold in the presence of nondenuded organ culture conditioned medium
(P<.01). Addition of
1-proteinase
inhibitor for 14 days caused a 60% decrease in elastolytic
activity in nondenuded organ cultures and a 27% reduction in ISMCs
compared with untreated controls (P<.05 for both). The
elastolytic activity, resolved as lytic bands on an elastin substrate
gel, reflected candidate enzymes, one at 76 kD and perhaps a doublet at
43 and 50 kD. Our study suggests that endothelial cells
release a soluble agent that enhances elastin-degrading activity in
the aorta and may at least partially account for the initiation of
neointimal formation.
Key Words: elastolytic activity neointimal formation aorta
1-proteinase inhibitor vascular disease
This article has been cited by other articles:
![]() |
M. Zureik, L. Robert, D. Courbon, P.-J. Touboul, L. Bizbiz, and P. Ducimetiere Serum Elastase Activity, Serum Elastase Inhibitors, and Occurrence of Carotid Atherosclerotic Plaques: The Etude sur le Vieillissement Arteriel (EVA) Study Circulation, June 4, 2002; 105(22): 2638 - 2645. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Barolet, N. Nili, A. Cheema, R. Robinson, M. K. Natarajan, S. O'Blenes, J. Li, M. R. Eskandarian, J. Sparkes, M. Rabinovitch, et al. Arterial Elastase Activity After Balloon Angioplasty and Effects of Elafin, an Elastase Inhibitor Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1269 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Cowan, P. L. Jones, and M. Rabinovitch Regression of Hypertrophied Rat Pulmonary Arteries in Organ Culture Is Associated With Suppression of Proteolytic Activity, Inhibition of Tenascin-C, and Smooth Muscle Cell Apoptosis Circ. Res., May 28, 1999; 84(10): 1223 - 1233. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |